Max S. Wicha
Director/Board Member at Van Andel Institute
Profile
Max S.
Wicha is the founder of OncoMed Pharmaceuticals, Inc. He is currently a trustee at Van Andel Institute.
Max S. Wicha active positions
| Companies | Position | Start |
|---|---|---|
Van Andel Institute
 Van Andel Institute Miscellaneous Commercial ServicesCommercial Services Van Andel Institute provides biomedical research and education services. Its services include antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI. | Director/Board Member | - |
Former positions of Max S. Wicha
| Companies | Position | End |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Van Andel Institute
Van Andel Institute Miscellaneous Commercial ServicesCommercial Services Van Andel Institute provides biomedical research and education services. Its services include antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI. | Commercial Services |
- Stock Market
- Insiders
- Max S. Wicha
